Combinostics has developed a unique machine learning approach for combining imaging data with other patient data such as molecular tests, genetic tests and neuropsychological tests, to create a more intelligent analysis of all available data. This will support doctors in
diagnosing complex diseases earlier and more precisely. Whereas Combinostics initially focuses on dementia, its core technology may be applied to several other disease areas.
“At LEO Innovation Lab we are constantly aiming to find partners who can help us develop the technologies that can improve the lives of people with skin diseases”, said Kristian HartHansen, CEO of LEO Innovation Lab. “The way Combinostics uses algorithms is very interesting to us, as dermatology sees some of the same needs for faster and easier diagnosing and prediction as the neurodegenerative disease area does, and we saw an opportunity in working together”.
Need for health data analytics
“The adoption of electronic health records, new biomarkers, wearable devices and more advanced imaging techniques means that clinicians are faced with rapidly increasing amounts of data. Today, a large portion of these data is left unexploited”, said Lennart Thurfjell, co-founder and CEO of Combinostics. “We have created a tool to put this data to work, and the Investments made by LEO Innovation Lab and other investors help us accelerate bringing this technology to the market”.
Combinostics’ first product, a tool for clinical decision support in dementia, is expected to go live with partnering clinics and hospitals within a couple of months In this seed round, Combinostics has secured funding not only from LEO Innovation Lab, but also from previous investors and from Brade Oy and M1 Capital Oy, both veteran investors in the Finnish eHealth community. “Digital Health is an area of particular interest to us, and we are intrigued by Combinostics’ approach to combine large amounts of data in a way that is intuitive for the clinician” says Harry Brade, Board Member of Brade Oy.
Find out more: http://www.combinostics.com/
FiBAN's news about startup investing.